Business - Briefly   

Dr. Reddy's to launch Lansoprazole in U.S.

HYDERABAD: Dr. Reddy's Laboratories (DRL) will be launching Lansoprazole delayed-release capsules (15 mg and 30 mg), a bio-equivalent generic version of Prevacid delayed-release capsules, in the U.S. market, says a release. Launch preparations are complete and shipments will commence shortly, adds the release.

— Special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Sub-panel to submit report on MFIs in three months
Nokia demonstrates high-speed 4G network
Bajaj Auto net profit zooms
Court sets time limit for RBI to decide on TMB share transfer
Canon launches new range of products
Sensex sheds 186 points
IOC to commission Paradip refinery by early 2012
Ceat expands Nashik plant capacity
Malabar Gold to expand
SEIKO opens exclusive boutique
Aegis acquires Actionline Argentina
HDFC Bank Q2 net up 33 %
Direct tax collections up 19% in first half
CIL issue subscribed 1.7 times on second day
Polaris Q2 profit up 37 %
Exchange Rates
Bullion Rates
SBH profit raises 35% in first half
State Bank of Mysore net up 13 %
Dr. Reddy's to launch Lansoprazole in U.S.
LVB raises interest rates on deposits
Carlson to expand India operations
Everonn in pact with University of Madras
New Director on NLC Board

Copyright © 2010, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu